Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report ; volume:19 ; number:1 ; day:18 ; month:3 ; year:2019 ; pages:1-5 ; date:12.2019
BMC cancer ; 19, Heft 1 (18.3.2019), 1-5, 12.2019
- Creator
-
Jin, Mengqi
Hu, Yongxian
Wu, Wenjun
Luo, Yi
Tan, Yamin
Yu, Jian
Jin, Aiyun
Yang, Luxin
Huang, He
Wei, Guoqing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-5464-0
- URN
-
urn:nbn:de:101:1-2019041101333411535878
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:53:33+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jin, Mengqi
- Hu, Yongxian
- Wu, Wenjun
- Luo, Yi
- Tan, Yamin
- Yu, Jian
- Jin, Aiyun
- Yang, Luxin
- Huang, He
- Wei, Guoqing
- SpringerLink (Online service)
Other Objects (12)
Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient
Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation
Haploidentical Stem Cell Transplantation for Hematological Disorders: Real-World Experience from India
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
Survival and functional immune reconstitution after haploidentical stem cell transplantation in Atm-deficient mice
Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient
Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation
Haploidentical Stem Cell Transplantation for Hematological Disorders: Real-World Experience from India
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
Survival and functional immune reconstitution after haploidentical stem cell transplantation in Atm-deficient mice
Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient
Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation
Haploidentical Stem Cell Transplantation for Hematological Disorders: Real-World Experience from India
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?